Talis Biomedical Corporation (TLIS)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

0.7952

-0.0025

(-0.31%)

At close: 04:00PM EDT

0.8100

+0.01

(+1.86%)

After hours:

07:12PM EDT

Advertisement

Yahoo Finance will soon be upgrading our Conversations message board platform to provide a better experience for our users. Only comments published since April 21, 2021 will be visible on Yahoo Finance after the upgrade. If you wish to download and save any of your older comments, please submit a request via the Privacy Dashboard by no later than Aug. 15, 2022.

S
Talis continued to make progress on its ability to manufacture the Talis One™ system at scale. Talis successfully implemented modifications to manufacturing processes, quality controls and supply conformance resulting in improved quality and yield of cartridges and instruments.

Based on evolving market dynamics with COVID testing and the current financial environment, Talis has discontinued investment in commercialization of its stand-alone COVID-19 assay under Emergency Use Authorization. As part of this decision, the company is refocusing its resources on large and long-term market opportunities in Women’s and Sexual health markets, beginning with a multiplex panel for Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG), which is currently under development.

“We have an innovative, high-performing platform with Talis One, evidence that we can manufacture cartridges and instruments at scale and $165 million in cash to execute on our strategy,” said Rob Kelley, chief executive officer of Talis.
J
There is no shortness on covid tests.
And todays tests are better and cheap.

This company is too late.

They should stop and pay out the cash.
J
Volume coming in
Bullish
S
Baker Brothers Advisors and Rob Kelley are trying to rob the minority shareholders.
The stock is trading at all time low and the net cash value is more than $3 per share.
This is criminal.
J
How about a $2 cash dividend?
R
https://tradeideas.tips/SPSA
N
https://tradeideas.tips/8YO0E
W
https://tradeideas.tips/Practice-Test-Invest
M
Help, help. I am drowning. Blub, blub, blub.....
Bearish
J
It doesn't matter. They've already stated revenue run up in 2022. It's all about their projections. If the project 5-10mil in q4 that's a lot of demand and we'll launch. If they project less than a mil it's gonna hurt. If they don't project at all I'm out.
S
WHY SO MUCH CASH?
U
Baker Bros own 37 million shares. Hmmm....
R
I will hold and wait for the application to be approved for government emergency use...
Bullish
B
Took a small position yesterday.
Bullish
U
$NNOX conversation
$NNOX, $BFLY and $TLIS will all catch upgrades, etc when orders are announced and price targets catapult shares. It's basically a very likely positive newsflow, upgrades versus short passions.
B
BIG BIG development today. Huge news. They finally have a product. Added in pre-market. This is going way higher IMO. This is what we all have been waiting for for over a year. Can't believe it finally happened!
B
OUCH! Well, I'm in at these levels. They have a ton of cash...about 2x the current market cap. That doesn't make any sense. Great time to get in and at least ride to a short term bounce.
U
$NNOX conversation
$NNOX going much higher. It's a major break-through, much needed. $TLIS medical testing tech also worth a close look. Baker Bros went in for 37 million shares!
T
Nothing special about their system, which hasn't even been approved. At $25 per test, it's too expensive for regular Covid testing. Hugely overvalued.
S
this low floater is a pure gift trading heavily below cash balance ( $44 m valuation vs cash balance of $233 m ) and they an FDA approved covid test system ...fair value should be closer to 10 dollars .GL
Bullish